Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Talk with the Experts: Clinical Case Studies and Treatment Decisions in Acute Myeloid Leukemia and Myelofibrosis
July 2024
Catch up on this expert-led Satellite Symposium, titled ‘Talk with the Experts: Clinical Case Studies and Treatment Decisions in Acute…
Read more
11th November 2022
A Global Perspective on Emerging BTK Inhibitor Therapy Data for CLL and MCL
Not able to attend the Expert Roundtable Discussion in Paris? Access the on-demand webcast here. This interactive event features expert perspectives on current and emerging uses of BTK inhibitors for CLL and MCL. Topics include:
5th September 2022
Latest updates in Advanced Systemic Mastocytosis from EHA 2022
Latest updates in Advanced Systemic Mastocytosis from EHA 2022. Targeting systemic mastocytosis. Update in Haematology session EHA 2022, Prof. Olivier Hermine introduces the session on overcoming the challenges in diagnosis and management of advanced systemic macrocytosis.
20th August 2022
Increasing Awareness in Beta-Thalassemia
This series of webinars focusses on Beta-Thalassemia. These are scientific presentations and discussions for the purpose of scientific exchange.
16th August 2022
Is Complete Response Enough? An Expert Look Towards the Future of Higher-Risk MDS Treatment
This satellite symposium discusses current key topics in higher-risk MDS, including treatment outcome measures
21st July 2022
New Treatment Options in Paediatric Thalassemia
The third of our six-part series focuses on new treatment options in paediatric thalassemia with expert Dr Immacolata Tartaglione, paediatrician at University of Campania Luigi Vanvitelli in Napoli, Italy.
31st May 2022
Novel targets for therapy in TD β-Thalassaemia
The second of our six-part series focusing on increasing awareness of β-thalassaemia features Khaled Musallam, Clinical Professor at…
25th May 2022
CME-Accredited Webinar on Biosimilars within Haematology & Oncology
This presidential debate-style discussion explores the topic of biosimilars within haematology and oncology.
13th May 2022
Jazz-Sponsored Symposium - High-risk AML* in 2022: what is the go-to strategy?
*High-risk AML defined as therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC)
Loading posts...
« Previous
1
2
3
4
5
…
8
Next »